Torres, Fernando et al
"Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy Results from a Phase 2 randomized, parallel group, placebo-controlled trial." European Respiratory Journal
(2019):
1901030.
Web. 18 April. 2024.